Categoría: News
-
Scientists Regenerate Various Tissue Types by Stimulating the Body’s Own Stem Cells
As an alternative to treating patients with someone else’s stem cells, researchers have improved upon the process of stimulating the body’s own reservoir of endogenous adult stem cells.
-
Physical Exercise Stimulates Neural Stem Cells and Sharpens Cognitive Function
A Harvard Medical School professor starts a new fad when he discovers the link between physical exercise, brain stem cells, and intelligence.
-
Adult Stem Cell «Beads» are Used in the Treatment of Stroke
Tiny beads packed with bioengineered stem cells are used to treat patients for stroke.
-
Genzyme on Track to Meet 2011 Financial Goal
After reporting strong fourth-quarter growth, Genzyme announces an optimistic economic forecast.
-
Cord Blood America Begins a Media Campaign via Social Networking Websites
The umbilical cord blood stem cell preservation company, Cord Blood America, announces a new campaign to engage the attention and interest of clients, investors and the general public through the new platform of social networking technology.
-
International Stem Cell Corporation Receives First Round of Funding
The California based biotechnology company ISCO receives the first $1 million tranche of private equity funding.
-
Anthrogenesis Receives Another Patent for Placental Stem Cell Innovation
Anthrogenesis Corporation, a division of Celgene, is awarded yet another U.S. patent for inventions related to methods of deriving adult stem cells from human placentas.
-
U.S. Doctor Plans Stem Cell Fact-Finding Mission to China
A U.S. doctor has been invited to visit China as part of a fact-finding mission on the current state of stem cell therapies that are only available outside of the United States.
-
Neuralstem Files FDA Application for ALS Adult Stem Cell Trial
The stem cell company Neuralstem has filed an application with the FDA to begin the first clinical trials ever to be conducted with adult stem cells in the treatment of amyotrophic lateral sclerosis.
-
Genzyme Receives FDA Approval for Mozobil
The U.S. Food and Drug Administration has granted marketing approval for Mozobil, Genzyme’s patented drug which stimulates the mobilization of autologous adult stem cells, now available for the treatment of non-Hodgkin’s lymphoma and multiple myeloma.